Authors of this study showed that, by impeding the binding of YY1 to the MMP-14 promoter, an AGO2–miR-584-3p complex can suppress the tumorigenesis and aggressiveness of gastric cancer cells, both in cell lines and xenograft tumors [81]. This evidence concerns the gene AGO2 and gastric cancer.